Upstream Bio, Inc.UPBEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
TCI Co., Ltd. is a Taiwanese contract development and manufacturing organization (CDMO) specialising in the research, development and production of functional beverages, dietary supplements and skincare products. Headquartered in the Neihu Technology Park in Taipei, TCI evolved from an original trading company founded in 1980 into a CDMO group serving clients across Asia, Europe and North America, and is publicly traded on Taiwan's over-the-counter market under the code 8436.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| FMR LLC | 11.82% | 6.1M | — | 2024-11-07 |
| OrbiMed Advisors LLC | 8.90% | 4.6M | — | 2024-10-17 |
| BCLS Fund III Investments, LP | 4.30% | 2.3M | — | 2024-10-18 |
Insider Transactions
Net 90d: −$46.6K · buys $0 / sells $46.6KRange:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-16 | GRAY MICHAEL | CFO and COO | Sell (open market) | 852 | $9.29 | $7.9K |
| 2026-03-16 | Allison Ambrose | General Counsel | Sell (open market) | 475 | $9.29 | $4.4K |
| 2026-03-16 | Aaron Deykin | Chief Medical Officer | Sell (open market) | 894 | $9.29 | $8.3K |
| 2026-03-16 | Sutherland Everett Rand | Chief Executive Officer | Sell (open market) | 2.1K | $9.29 | $19.4K |
| 2026-03-16 | Adam Houghton | Chief Business Officer | Sell (open market) | 699 | $9.29 | $6.5K |
1–5 of 5